‘Iron Man’ star Terrance Howard mocked over unrecognizable new look: ‘His Farrah Fawcett era’
Oscar-nominated actor Terrence Howard sat down for a new interview this week to air his alleged mistreatment and underpayment by Hollywood – but it seems many viewers were too distracted by his new hair-do to listen to what he had to say.
Howard, 55, who has appeared in films including Hustle & Flow, Crash and The Butler, recently appeared on the online talk show Straighttalkphanee to explain why he’s suing giant Hollywood talent agency CAA (Creative Artists Agency).
He says he was paid $325,000 per episode per episode for his popular TV show Empire, while The Big Bang Theory cast was paid $2 to 3 million per episode, despite Empire having more viewers.
What goes unremarked upon in the interview – but what immediately caught most viewers’ eye – is Howard’s new hair: A red bob, complete with Charlie’s Angels-esque Farrah Fawcett flick.
“Imma try to watch the video and give him a chance before commenting on the hair but it’s hard,” one person commented under the video.
“Bro got the Farah Fawcett look and wants to be taken seriously,” wrote another person – a common comparison.
“I’m sorry, I know he’s talking about a serious topic but I can’t get past the fact that Terrence Howard is in his Farrah Fawcett era,” wrote another commenter.
“Are we supposed sit here and ignore Terrence’s wig?” asked another, while one follower said his new look made him resemble “a pimp from the 70s.”
Howard has made frequent complaints about his pay as an actor in the past.
In 2008, it was announced he would not be reprising his role as Robert Downey Jr’s sidekick in an Iron Man sequel.
He said he was sacked over his refusal to take a major pay cut – claim which Marvel Studios publicly disputed at the time. In interviews, Howard laid the blame squarely at his former co-star, Downey Jr.
“It turns out that the person I helped become Iron Man … when it was time to re-up for the second one, [he] took the money that was supposed to go to me,” he claimed.